Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation Plans (Tables)

v3.20.4
Stock-Based Compensation Plans (Tables)
12 Months Ended
Jan. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
Total stock-based compensation expense was recorded in the accompanying consolidated statements of operations as follows:
  Year Ended
  January 30, February 1, February 2,
(in millions) 2021 2020 2019
Cost of sales $ 15.4  $ 12.9  $ 12.1 
Selling, general and administrative expenses 68.5  48.5  51.2 
Total stock-based compensation expense $ 83.9  $ 61.4  $ 63.3 
Excess tax benefit (deficit) on stock-based compensation
recognized in the Provision for income taxes
$ (2.8) $ 3.8  $ (1.3)
Schedule of Restricted Stock Units Activity
The following table summarizes the status of service-based RSUs as of January 30, 2021 and changes during the year then ended: 
Number of Shares Weighted Average Grant Date Fair Value
Nonvested at February 1, 2020 1,049,081  $ 95.17 
Granted 850,132  73.24 
Vested (533,032) 91.05 
Forfeited (100,965) 82.78 
Nonvested at January 30, 2021 1,265,216  $ 83.16 
Schedule of Nonvested Performance-based Units Activity
The following table summarizes the status of PSUs as of January 30, 2021 and changes during the year then ended: 
Number of Shares Weighted Average Grant Date Fair Value
Nonvested at February 1, 2020 320,500  $ 99.29 
Granted 428,377  74.46 
Vested (221,876) 88.12 
Forfeited (103,729) 85.84 
Nonvested at January 30, 2021 423,272  $ 82.67 
Schedule of Stock Option Activity
The following tables summarize information about options outstanding at January 30, 2021 and changes during the year then ended:
  Number of Shares Weighted Average Per Share Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value
(in millions)
Outstanding, beginning of period 205,893  $ 76.87     
Granted 6,412  89.77     
Exercised (94,890) 74.19     
Forfeited (358) 76.97     
Outstanding, end of period 117,057  $ 79.75  4.4 $ 2.6 
Options vested and exercisable at January 30, 2021 117,057  $ 79.75  4.4 $ 2.6